SARA GERACI: Open Payments
NPI 1962807891 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,542 in 64 payments from 21 companies in 2025. Trend: 2023 $841 · 2024 $1,042 · 2025 $1,542
Food & beverage: $1,542
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 5 | $184 |
| Lundbeck LLC | 12 | $178 |
| TG Therapeutics, Inc. | 6 | $146 |
| Vanda Pharmaceuticals Inc. | 5 | $128 |
| ARGENX US, INC. | 4 | $122 |
| Eisai Inc. | 4 | $120 |
| Biogen, Inc. | 5 | $110 |
| UCB, Inc. | 3 | $74 |
| Merz Pharmaceuticals, LLC | 2 | $69 |
| ABBVIE INC. | 3 | $62 |
Products named: LEQEMBI, BRIUMVI, PONVORY, VYEPTI, VYVGART HYTRULO, Xeomin, XYWAV, Briviact.
Industry payments across AK — which companies pay providers there.
